Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Biochimie|March 30, 2010
Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out miceLisa Sevenich, Sascha Hagemann, Christina Stoeckle, et al.Biological Chemistry|July 31, 2003
Toward computer-based cleavage site prediction of cysteine endopeptidasesTobias Lohmüller, Daniel Wenzler, Sascha Hagemann, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 27, 2010
Reducing sample complexity of polyclonal human autoantibodies by chromatofocusingSascha Hagemann, Alexander Faude, Monika Rabenstein, et al.European Journal of Cell Biology|February 1, 2005
The human cysteine protease cathepsin V can compensate for murine cathepsin L in mouse epidermis and hair folliclesSascha Hagemann, Thomas Günther, Julia Dennemärker, et al.Journal of Chemical Information and Computer Sciences|January 27, 2004
An open source protein gel documentation system for proteome analysesDaniel Faller, Thomas Reinheckel, Daniel Wenzler, et al.Journal of Cell Science|August 5, 2005
The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recyclingThomas Reinheckel, Sascha Hagemann, Susanne Dollwet-Mack, et al.The Journal of Biological Chemistry|October 19, 2007
Cell type-specific functions of the lysosomal protease cathepsin L in the heartDaniel Spira, Jörg Stypmann, Desmond J Tobin, et al.Journal of Proteome Research|May 14, 2014
Proteome analysis of a hepatocyte-specific BIRC5 (survivin)-knockout mouse model during liver regenerationThilo Bracht, Sascha Hagemann, Marius Loscha, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2014
(Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allograftsHenning Reis, Jeremias Wohlschläger, Sascha Hagemann, et al.Oncotarget|January 7, 2017
Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCCLeona L Pott, Sascha Hagemann, Henning Reis, et al.Pageof 2